317 related articles for article (PubMed ID: 11904738)
21. [IgM myeloma. Apropos of a case].
Heron JF; Guaydier G; Loyau G; Laniece M; Mandart JC; Borel B; L'Hirondel JL; Dumas M; Foucault JP
Sem Hop; 1976 Dec; 52(44):2549-52. PubMed ID: 188198
[No Abstract] [Full Text] [Related]
22. Multiple myeloma: recognition and management.
George ED; Sadovsky R
Am Fam Physician; 1999 Apr; 59(7):1885-94. PubMed ID: 10208707
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Owen RG; Treon SP; Al-Katib A; Fonseca R; Greipp PR; McMaster ML; Morra E; Pangalis GA; San Miguel JF; Branagan AR; Dimopoulos MA
Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118
[TBL] [Abstract][Full Text] [Related]
24. IgM myeloma and Waldenstrom's macroglobulinemia: a distinct clinical feature, histology, immunophenotype, and chromosomal abnormality.
Chehal A; Taher A; Shamseddine A
Clin Lab Haematol; 2003 Jun; 25(3):187-90. PubMed ID: 12755797
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders.
Morra E; Cesana C; Klersy C; Barbarano L; Varettoni M; Cavanna L; Canesi B; Tresoldi E; Miqueleiz S; Bernuzzi P; Nosari AM; Lazzarino M
Leukemia; 2004 Sep; 18(9):1512-7. PubMed ID: 15322559
[TBL] [Abstract][Full Text] [Related]
26. IgM myeloma, a distinct entity in the spectrum of B-cell neoplasia.
Zarrabi MH; Stark RS; Kane P; Dannaher CL; Chandor S
Am J Clin Pathol; 1981 Jan; 75(1):1-10. PubMed ID: 6779622
[TBL] [Abstract][Full Text] [Related]
27. [Bilateral malignant exophthalmia as a manifestation of IgM multiple myeloma].
Trecan G; Dufier JL; Blatrix C; Aftimos G; Saraux H; Thomas M
Sem Hop; 1977 Oct 9-16; 53(34-35):1867-72. PubMed ID: 201032
[TBL] [Abstract][Full Text] [Related]
28. Should bone marrow examination be routinely performed for the diagnosis of monoclonal gammopathy of undetermined significance?
Elis A; Radnay J; Shapiro H; Itzhaky D; Manor Y; Lishner M
Isr Med Assoc J; 2006 Dec; 8(12):840-2. PubMed ID: 17214099
[TBL] [Abstract][Full Text] [Related]
29. Malignant transformation in IgM monoclonal gammopathy of undetermined significance.
Montoto S; Rozman M; Rosiñol L; Nadal E; Giné E; Aymerich M; Ferrer A; Esteve J; Bosch F; López-Guillermo A; Bladé J; Montserrat E
Semin Oncol; 2003 Apr; 30(2):178-81. PubMed ID: 12720132
[TBL] [Abstract][Full Text] [Related]
30. [Neurologic manifestations of monoclonal gammapathies].
Uldry PA; Steck AJ; Regli F
Schweiz Med Wochenschr; 1984 Nov; 114(47):1678-85. PubMed ID: 6096963
[TBL] [Abstract][Full Text] [Related]
31. Immunochemical studies in a patient with Waldenstrom's macroglobulinemia.
Mir-Ahmadian M; Rahbar S; Heidery H; Hajaliloo G
Acta Med Iran; 1978; 21(1):39-46. PubMed ID: 110036
[TBL] [Abstract][Full Text] [Related]
32. Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathy.
Morra E; Cesana C; Klersy C; Varettoni M; Cavanna L; Canesi B; Tresoldi E; Barbarano L; Lazzarino M;
Semin Oncol; 2003 Apr; 30(2):172-7. PubMed ID: 12720131
[TBL] [Abstract][Full Text] [Related]
33. Differential diagnosis of Waldenstrom's macroglobulinemia from other low-grade B-cell lymphoproliferative disorders.
Pangalis GA; Kyrtsonis MC; Kontopidou FN; Vassilakopoulos TP; Siakantaris MP; Dimopoulou MN; Kittas C; Angelopoulou MK
Semin Oncol; 2003 Apr; 30(2):201-5. PubMed ID: 12720136
[TBL] [Abstract][Full Text] [Related]
34. Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Kyle RA; Treon SP; Alexanian R; Barlogie B; Björkholm M; Dhodapkar M; Lister TA; Merlini G; Morel P; Stone M; Branagan AR; Leblond V
Semin Oncol; 2003 Apr; 30(2):116-20. PubMed ID: 12720119
[TBL] [Abstract][Full Text] [Related]
35. Multiple myeloma with bone marrow biopsy features simulating concomitant chronic idiopathic myelofibrosis.
Schmidt U; Ruwe M; Leder LD
Nouv Rev Fr Hematol (1978); 1995; 37(2):159-63. PubMed ID: 7644355
[TBL] [Abstract][Full Text] [Related]
36. IgM myeloma--its distinction from Waldenström's macroglobulinemia.
Takahashi K; Yamamura F; Motoyama H
Acta Pathol Jpn; 1986 Oct; 36(10):1553-63. PubMed ID: 3099541
[TBL] [Abstract][Full Text] [Related]
37. Immunophenotypic aberrations, DNA content, and cell cycle analysis of plasma cells in patients with myeloma and monoclonal gammopathies.
Lima M; Teixeira Mdos A; Fonseca S; Gonçalves C; Guerra M; Queirós ML; Santos AH; Coutinho A; Pinho L; Marques L; Cunha M; Ribeiro P; Xavier L; Vieira H; Pinto P; Justiça B
Blood Cells Mol Dis; 2000 Dec; 26(6):634-45. PubMed ID: 11358356
[TBL] [Abstract][Full Text] [Related]
38. Clinical Presentation and Gene Expression Profiling of Immunoglobulin M Multiple Myeloma Compared With Other Myeloma Subtypes and Waldenström Macroglobulinemia.
Atrash S; Zhang Q; Papanikolaou X; Stein C; Abdallah AO; Barlogie B
J Glob Oncol; 2018 Sep; 4():1-8. PubMed ID: 30241189
[TBL] [Abstract][Full Text] [Related]
39. Concomitant Waldenstrom macroglobulinemia and IgA plasmablastic myeloma in a patient with untreated IgM paraproteinemia: sequential development of biclonal B-cell neoplasms over a 10-year period in a single individual.
Wang E; Kulbacki E; Stoecker M
Hum Pathol; 2012 Jul; 43(7):1135-41. PubMed ID: 22404949
[TBL] [Abstract][Full Text] [Related]
40. [Rare forms of paraproteinemic hemoblastosis].
Andreeva NE
Ter Arkh; 1984; 56(6):59-63. PubMed ID: 6433500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
